Boehringer, Tricella, Appnovation on putting patient centricity into practice

Cortexyme Announces Clinical Hold on Atuzaginstat’s Investigational New Drug Application

Molecular Targeting Technologies, Inc., Thomas Jefferson University and North China Pharmaceutical Co., Ltd Announced the Chinese Approval for a Rabies Drug

Labcorp to Offer Risk-Scoring Test for People With Advanced Liver Fibrosis Due to NASH

Melanoma Research Alliance Statement on FDA Approval of Tebentafusp, the First Drug for Treating Metastatic Uveal Melanoma

NANOBIOTIX Announces Publication of New Preclinical Immunotherapy Data Showcasing the Combination Potential of NBTXR3 With anti-PD-1 and anti-CTLA-4